January 20, 2022
FDA: Class I recall of Getinge Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems
Editor's Note
The Food and Drug Administration (FDA) on January 19 identified the recall by Getinge of its Vaporizer Sevoflurane Maquet Filling for Flow Family Anesthesia Systems as Class I, the most serious.
The recall was initiated because of the potential chemical breakdown of Sevoflurane that may result in inhalation and/or skin exposure to harmful chemicals.
There have been eight complaints and no reported deaths or injuries.
Distribution dates were February 16, 2021 to October 30, 2021.
Free Daily News
- United Surgical Partners agrees to $1.48M settlement in 401(k) fee lawsuit
- Healthcare M&A activity set to rebound in 2025 amid stricter state oversight
- High participation in ASCQR program continues, March deadline for reconsideration requests
- Study: Preoperative stereotactic radiosurgery shows promise in brain metastases management
- Senate report: Private equity endangers patient care in underserved hospitals
- Study: Postoperative thirst often overlooked by OR, ward nurses
- FDA draft guidance addresses pulse oximeter accuracy, AI devices
- AAMI updates sterilization materials compatibility guidance
- Study: Esophagectomy outcomes worse at private equity hospitals
- Study: Black CABG patients disadvantaged in accessing best hospitals
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement